Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women (Lancet, 1992)

(untitled) - Early Breast Cancer Trialist's Collaborative Group